| Children | Adults |
---|---|---|
Variable | (n1 = 125) | (n2 = 125) |
Demographics | ||
Age in years, median (IQRa) | 1 (0–3) | 60 (42–75) |
Male gender, n (%) | 70 (56) | 66 (53) |
Ethnicity, n (%) | Â | Â |
European and other | 56 (45) | 75 (60) |
Maori | 22 (17) | 13 (10) |
Pacific | 36 (29) | 19 (15) |
Asian | 11 (9) | 18 (15) |
Self-defined healthb, n (%) | Â | Â |
Excellent | 51 (42) | 11 (9) |
Very good | 32 (26) | 39 (32) |
Good | 25 (20) | 44 (36) |
Fair | 5 (4) | 20 (16) |
Poor | 10 (8) | 9 (7) |
Smoking history (adults only) | Â | Â |
Ever smoker, n (%) | - | 65 (50) |
Current smoker, n (%) | - | 18 (14) |
Clinical features of SARI illness | ||
Presenting syndromec, n (%) | Â | Â |
Suspected acute upper respiratory tract infection | 6 (5) | 3 (3) |
Suspected croup | 4 (3) | 0 (0) |
Suspected bronchiolitis | 42 (36) | 0 (0) |
Suspected pneumonia | 50 (42) | 47 (39) |
Exacerbation of adult chronic lung disease | 0 (0) | 11 (9) |
Exacerbation of asthma | 7 (6) | 7 (6) |
Exacerbation of childhood chronic lung disease | 1 (1) | 0 (0) |
Respiratory failure | 0 (0) | 3 (3) |
Febrile illness with respiratory symptoms | 3 (3) | 30 (25) |
Other suspected acute respiratory infection | 5 (4) | 18 (15) |
Length of stay in days, median (IQRa) | 3 (2–5) | 3 (2–6) |
Intensive care unit admission, n (%) | 21 (17) | 4 (3) |
Respiratory viral testing and results | ||
Influenza virus identifiedd, n (%) | 26 (21) | 31 (25) |
Non-influenza respiratory virus identifiede, n (%) | 80 (81) | 27 (25) |
Discharge diagnosis categoryf | ||
Respiratory | 119 (95) | 93 (74) |
Cardiovascular | 0 (0) | 6 (5) |
Infectious diseases | 4 (3) | 6 (5) |
Other organ systems | 2 (2) | 20 (16) |